Remove Clinical Supply Remove Development Remove FDA Approval Remove Reagent
article thumbnail

IN FOCUS: Syngene International

Pharmaceutical Technology

The company has been ranked in the Business Expansion and Research and Development categories in the Pharmaceutical Technology Excellence Rankings. Initially centered on Librela®, this agreement paves the way for developing and manufacturing other molecules in the coming years. until 2026. until 2026.